Mary N. Brown

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

AstraZeneca (Sweden)(Current)

AstraZeneca (United States)

AstraZeneca (United Kingdom)

Mary N. Brown is an author at AstraZeneca (Sweden) specializing in pharmacology, mitogen-activated protein kinase kinase, and obstructive lung disease.

ORCID

Publications per year

2018–2022

Publications

The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial

Naimish Patel, Danen Cunoosamy, Malin Fagerås et al. · International Journal of COPD · 2018 · 51 citations · Full text

Medicine, Immunology, Pharmacology +17

Efficacy and safety of AZD7594, an inhaled non-steroidal selective glucocorticoid receptor modulator, in patients with asthma: a phase 2a randomized, double blind, placebo-controlled crossover trial

Mary N. Brown, Rainard Fuhr, Jutta Beier et al. · Respiratory Research · 2019 · 26 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

The absolute risk of incident type 2 diabetes following exposure to systemic corticosteroids in selected steroid‐related and phenotypic groups

Phil Ambery, Samuel Adamsson Eryd, Sara Jenkins‐Jones et al. · Diabetes Obesity and Metabolism · 2022 · 10 citations

Medicine, Endocrinology, Pharmacology +16

1–3 of 3